Axon Enterprise, Inc. (AXON) Balance Sheet

The balance sheet has more than doubled in just over two years, reflecting aggressive M&A and organic growth. However, the composition of this expansion—goodwill jumping from $308.5M to $1.9B—suggests that a significant portion of asset growth is intangible, which may carry impairment risk if growth decelerates. The equity base has also grown from $1.8B to $3.7B, but this is partly due to stock-based compensation, which has diluted shareholders.

The debt increase appears tied to funding acquisitions, as evidenced by the goodwill spike. While the D/E ratio remains manageable, the absolute debt level has grown 2.5x in two years, and interest coverage may be pressured given the negative operating margin of -2.2% in 2026Q2. Investors should monitor whether the acquired assets generate sufficient cash flow to service this debt, especially if the regulatory environment forces changes to the bundling model.

The asset mix has shifted dramatically toward intangibles, reflecting the company's pivot to software and acquisitions. This increases the risk of impairment if growth expectations are not met, especially given the premium paid for targets. The low PPE intensity (4.5% of assets) confirms an asset-light model, but the reliance on acquired intangibles means that the quality of earnings is tied to the successful integration of these acquisitions.

While retained earnings have nearly doubled, the equity base has been bolstered by significant SBC, which is a non-cash expense that inflates equity without corresponding cash generation. The cumulative SBC over the last ten quarters ($1.2B) exceeds cumulative net income ($700M), indicating that reported equity quality is lower than it appears. This dilution may continue as the company uses equity as a currency for acquisitions and employee compensation.

The current ratio has declined from its peak but remains above 2, indicating adequate short-term liquidity. However, cash has decreased from $1.2B in 2025Q4 to $597.7M, partly due to acquisition outflows. Given the negative operating margin, the company may need to rely on debt or equity issuance to fund future growth, which could strain liquidity if capital markets tighten.

The consistent growth in deferred revenue, despite a temporary dip to zero in 2025Q4 (likely due to a reclassification), suggests strong demand for Axon's subscription bundles. This provides forward visibility into revenue, but investors should note that the 2025Q4 zero figure may indicate a change in accounting presentation rather than a true decline. The RPO, if disclosed, would offer further clarity on the committed backlog.